BPC 157 Dosing (Common Protocols), Oral Subcutaneous, 500 mcg daily, Duration: 6 weeks, Intramuscular Peritendinous, 1 mg daily, Duration: 6 weeks, Note:, Not approved by FDA or If you are running BPC 157, the biggest mistake is treating it like a random add on instead of a protocol., The research around tissue repair signaling is interesting, but your real world BPC 157 Peptide and Lyme Disease: Tissue Repair and Immune Support Buy BPC 157 (15mg) Order Research Peptides Medica Depot